Victoria R Nachar

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 6

Top Topics

Sickle Cell Disease

Affordable Care Act

Hodgkin Lymphoma

Patient Reported Outcomes

Top Venues

Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners

JCO oncology practice

Annals of hematology

This page only lists publications with an associated author ORCID identifier.

Publications

Christy J Khouderchah, Madeleine Ochs, Matthew Pianko, Zahra Mahmoudjafari, Jordan Snyder, Iman Ahmed, Erica Campagnaro, Victoria R Nachar
Administration of teclistamab in four patients with multiple myeloma requiring hemodialysis. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners (2024)
Victoria R Nachar, Anthony J Perissinotti, Bernard L Marini, Yasmin H Karimi, Tycel J Phillips
COVID-19 infection outcomes in patients receiving CD20 targeting T-cell engaging bispecific antibodies for B-cell non-Hodgkin lymphoma. Annals of hematology (2023)
Jacqueline C Dela Pena, Madeleine A King, Julia Brown, Victoria R Nachar
Incorporation of novel therapies for the management of sickle cell disease: A pharmacist's perspective. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners 28 (3) (2022)
Victoria R Nachar, Allison J Schepers
Clinical controversies in the treatment of cancer-associated venous thromboembolism. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners 27 (4) (2021)
Shannon M Hough, Rachel L McDevitt, Victoria R Nachar, Shawna Kraft, Anna Brown, Catherine Christen, David Frame, Jeffrey B Smerage
Chemotherapy Remote Care Monitoring Program: Integration of SMS Text Patient-Reported Outcomes in the Electronic Health Record and Pharmacist Intervention for Chemotherapy-Induced Nausea and Vomiting. JCO oncology practice 17 (9) (2021)
Adam C Robinson, Victoria R Nachar
Successful rechallenge of rituximab following severe rituximab-induced acute thrombocytopenia in a patient with splenic marginal zone lymphoma. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners 26 (5) (2019)